Federated Hermes, Inc. Rezolute, Inc. Transaction History
Federated Hermes, Inc.
- $50.2 Billion
- Q2 2025
A detailed history of Federated Hermes, Inc. transactions in Rezolute, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 14,034,712 shares of RZLT stock, worth $130 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
14,034,712
Previous 11,279,327
24.43%
Holding current value
$130 Million
Previous $32.7 Million
91.36%
% of portfolio
0.12%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding RZLT
# of Institutions
95Shares Held
59.4MCall Options Held
713KPut Options Held
19K-
Vanguard Group Inc Valley Forge, PA4.02MShares$37.4 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$33.1 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$28.2 Million0.0% of portfolio
-
Great Point Partners LLC Greenwich, CT3.03MShares$28.2 Million11.22% of portfolio
-
Marshall Wace, LLP London, X02.89MShares$26.8 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $361M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...